HY-145817B-10mg
|
MedChemexpress LLC
|
(R)-RP-6306 [CAS 2719793-91-4]
|
|
Cancer-programmed cell death
|
|
HY-145817B-100mg
|
MedChemexpress LLC
|
(R)-RP-6306 [CAS 2719793-91-4]
|
|
Cancer-programmed cell death
|
|
HY-145817B-25mg
|
MedChemexpress LLC
|
(R)-RP-6306 [CAS 2719793-91-4]
|
|
Cancer-programmed cell death
|
|
HY-145817B-5mg
|
MedChemexpress LLC
|
(R)-RP-6306 [CAS 2719793-91-4]
|
|
Cancer-programmed cell death
|
|
HY-145817B-50mg
|
MedChemexpress LLC
|
(R)-RP-6306 [CAS 2719793-91-4]
|
|
Cancer-programmed cell death
|
|
HY-A0068-5mg
|
MedChemexpress LLC
|
Aurothioglucose [CAS 12192-57-3]
|
|
Cancer-programmed cell death
|
|
HY-A0068-1mL
|
MedChemexpress LLC
|
Aurothioglucose [CAS 12192-57-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-B1285-100mg
|
MedChemexpress LLC
|
Dimercaprol [CAS 59-52-9]
|
|
Neuroscience-Neuromodulation
|
|
HY-B1285-1mL
|
MedChemexpress LLC
|
Dimercaprol [CAS 59-52-9] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
HY-W094581-1g
|
MedChemexpress LLC
|
Gold(III) chloride trihydrate [CAS 16961-25-4]
|
|
|
|
HY-W094581-500mg
|
MedChemexpress LLC
|
Gold(III) chloride trihydrate [CAS 16961-25-4]
|
|
|
|